Back
Neuphoria Therapeutics Inc. NEUP · Insights
Neuphoria Therapeutics Inc., a clinical stage biopharmaceutical company, develops novel allosteric i... Price2.76
Market Cap14.94 M
Float4.5 M
CountryUS
SectorHealthcare
ExchangeNASDAQ
OverviewFilingsInsightsDilutionNewsTranscriptsInsights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro